Cayman Islands
Cayman’s dementia response is fundamentally service-led and partnership-based, reflecting the structure of its wider health system. Clinical access is routed through GP gatekeeping, which directs patients to hospital diagnostics at HSA, specialist consultations, and, when appropriate, a private Memory Clinic. The island maintains on-site CT and MRI, while PET/CT is available through private providers, allowing a reasonable diagnostic work-up without routine overseas travel. These clinical services are complemented by the work of the Alzheimer’s & Dementia Association of the Cayman Islands (ADACI), which anchors community-facing support such as caregiver training, navigation assistance, home-safety advice, and the widespread rollout of Dementia Friends training across businesses, schools and frontline service sectors.
However, Cayman lacks a dementia-specific national plan, and key elements of the care pathway—particularly affordability and continuity, are shaped by insurance tiering, coverage limitations in SHIC basic plans, and the need for insurer approval for overseas diagnostics or emerging therapeutics. This creates variation in patient experience, especially for families requiring specialized assessments or ongoing support. As the population ages, the next gains are likely to come from strengthening community supports, broadening caregiver assistance, expanding dementia-friendly training across public services, and standardizing benefits and referral pathways to reduce inequity. Such measures would reinforce the service-led model while moving toward a more coordinated and predictable system of dementia care.
AD Rating
Diagnostic Pathway
Specialized Care
Caregiver Support
National Policies
Access to ATT-s
Highlights
Population
Median age
Health expenditure (% of GDP)
Diagnosis
Diagnosis
Show moreIn the Cayman Islands, dementia assessment generally begins with a GP and progresses to HSA or private neurology and psychiatry services, with Health City Cayman Islands offering a dedicated Memory Clinic. George Town concentrates cognitive testing, laboratory investigations, CT, and MRI, while advanced or sub-specialist care may require overseas referral. No national dementia waiting-time indicators or population screening programme has been established; instead, case-finding occurs opportunistically through primary care and family concerns. MMSE, MoCA, clock-drawing, and informant questionnaires can support clinical assessment. Mandatory insurance limits direct financial exposure, although coverage varies and families may still face co-pays, uncovered services, or offshore travel expenses. Routine dementia pathways do not include genetic testing, APOE, amyloid PET, or CSF and blood biomarkers, with complex cases potentially requiring overseas testing. ADACI supports families with information and care navigation.
Diagnosis pathway
The Cayman Islands uses a largely primary-care-led dementia pathway, with GPs identifying concerns and coordinating referrals to HSA or private neurology and psychiatry services. George Town hospital facilities provide most cognitive assessments, laboratory investigations, and neuroimaging, complemented by Health City Cayman Islands’ dedicated Memory Clinic. For investigations or specialist care unavailable locally, approved overseas treatment may be funded through CINICO or private insurance. Alongside clinical services, the Alzheimer’s & Dementia Association of the Cayman Islands supports families through education, care navigation, and caregiver guidance.
Cayman follows a predominantly GP-led pathway anchored in mandatory health insurance. Most people first raise cognitive or behavioural concerns with a family doctor, who acts as a gatekeeper and determines whether specialist input is required. From there, patients are commonly referred to neurology or psychiatry within the Cayman Islands Health Services Authority (HSA) or to private specialists. Diagnostic work-ups, neuroimaging, laboratory tests and cognitive assessments, are performed mainly through HSA’s hospital-based services in George Town, supplemented by additional specialist capacity at Health City Cayman Islands, which also advertises a dedicated Memory Clinic offering diagnostic and therapeutic services.
For investigations or sub-specialty care not available on-island, the system relies on overseas referral pathways. Public beneficiaries under Cayman Islands National Insurance Company (CINICO) can access care abroad with prior approval, similar to offshore referral models seen in other small-island jurisdictions, such as Aruba’s AZV. Some private plans also fund overseas diagnostics and treatment when medically necessary. Alongside clinical pathways, NGOs, particularly the Alzheimer’s & Dementia Association of the Cayman Islands (ADACI), play a navigation role by supporting families, providing educational resources, and helping carers understand available services.
Wait times
The Cayman Islands has no published national indicators for dementia-related waiting times. Imaging is generally accessible in George Town, although rehabilitation services may involve waitlists depending on capacity and demand. Overseas referrals can introduce further delays through approval and travel processes, while geographic differences may extend the time between GP assessment, specialist referral, and follow-up.
There are no published dementia-specific national waiting-time indicators. However, available signals suggest that routine CT and MRI is accessible at HSA and major private centers, with generally shorter waits in George Town, where radiology services are concentrated. Certain outpatient therapies, such as physiotherapy, speech therapy or cognitive rehabilitation, may operate waitlists depending on staffing levels and seasonal demand. When overseas referrals are required, the approval and travel processes introduce additional delays, and families may face logistical or financial barriers even when medical costs are covered. Overall, patients in urban areas benefit from faster access, while those in outer districts may experience longer intervals between GP assessment, referral, and specialist follow-up.
Diagnosis cost
Dementia diagnostic costs in the Cayman Islands are largely shaped by mandatory health insurance and individual coverage. CINICO supports eligible residents and may fund approved overseas referrals, while private insurance plans provide varying levels of diagnostic, specialist, and international coverage. Families may nevertheless face co-pays, deductibles, uncovered services, out-of-network charges, and travel or accommodation expenses for offshore care. These differences can influence provider choice, affordability, and the timing of dementia assessment.
All residents must hold health insurance, and coverage determines financial exposure during the diagnostic process. The public insurer CINICO covers civil servants, pensioners, veterans/seafarers and eligible low-income beneficiaries, including the option of overseas referral when local services are unavailable. Private insurance varies: basic Standard Health Insurance Contract (SHIC) plans provide limited outpatient diagnostics and restrict international care to major services, while comprehensive plans cover broader diagnostic work, specialist consultations, and medically necessary overseas care.
Out-of-pocket costs can arise through:
• co-pays or deductibles for outpatient imaging and specialist visits,
• services not included in SHIC benefits,
• out-of-network providers,
• travel, accommodation and incidental costs for offshore evaluations, even when CINICO or private plans approve the medical portion.
For families navigating dementia, these financial variations can shape diagnostic timing and choice of provider, contributing to differential access across the population.
Cognitive tests
Cayman does not operate a population-wide screening program for dementia. Instead, cognitive issues are identified through opportunistic case-finding during primary care visits or through concerns raised by family members. Specialists typically use internationally standardized brief tools, MMSE, MoCA, clock-drawing, and incorporate informant questionnaires to capture functional changes. Public facing initiatives such as “Dementia Friends” training and dementia friendly community efforts reinforce early help-seeking and awareness, helping people reach clinical services sooner.
Imaging tests
CT and MRI are widely available at HSA Radiology and across several private centers. The island also has nuclear medicine and PET/CT capacity within private providers such as Baptist Health Diagnostic Imaging and Smith Road Medical Center, which can support selected neurological evaluations. HSA documents PET access through partnered third-party providers. However, amyloid-PET, a key biomarker tool used in some countries for Alzheimer’s confirmation, is not described as a routine, publicly commissioned test in Cayman. Patients with complex or atypical presentations may therefore be referred overseas for advanced neurodiagnostic imaging.
Genetic tests
Genetic testing is not part of standard dementia work-ups. When indicated, for example, early-onset symptoms or strong familial clustering, clinicians arrange send-out tests to accredited international laboratories. APOE genotyping, relevant globally for counselling and monitoring around anti-amyloid therapies, is likewise obtained via overseas labs and specialist interpretation.
Biomarker tests
Routine blood and metabolic testing is available locally. However, CSF Alzheimer biomarkers (Aβ42/40, total-tau, phosphorylated-tau) and emerging blood-based biomarkers are not documented as standard practice within either HSA or private providers. In cases requiring biomarker clarification, clinicians rely on overseas consultations and external laboratory testing.
Cognitive Tests
Cognitive Tests
Cayman does not operate a population-wide screening program for dementia. Instead, cognitive issues are identified through opportunistic case-finding during primary care visits or through concerns raised by family members. Specialists typically use internationally standardized brief tools, MMSE, MoCA, clock-drawing, and incorporate informant questionnaires to capture functional changes. Public facing initiatives such as “Dementia Friends” training and dementia friendly community efforts reinforce early help-seeking and awareness, helping people reach clinical services sooner.
Imaging Tests
Imaging Tests
CT and MRI are widely available at HSA Radiology and across several private centers. The island also has nuclear medicine and PET/CT capacity within private providers such as Baptist Health Diagnostic Imaging and Smith Road Medical Center, which can support selected neurological evaluations. HSA documents PET access through partnered third-party providers. However, amyloid-PET, a key biomarker tool used in some countries for Alzheimer’s confirmation, is not described as a routine, publicly commissioned test in Cayman. Patients with complex or atypical presentations may therefore be referred overseas for advanced neurodiagnostic imaging.
Genetic Tests
Genetic Tests
Genetic testing is not part of standard dementia work-ups. When indicated, for example, early-onset symptoms or strong familial clustering, clinicians arrange send-out tests to accredited international laboratories. APOE genotyping, relevant globally for counselling and monitoring around anti-amyloid therapies, is likewise obtained via overseas labs and specialist interpretation.
Biomarker Tests
Biomarker Tests
Routine blood and metabolic testing is available locally. However, CSF Alzheimer biomarkers (Aβ42/40, total-tau, phosphorylated-tau) and emerging blood-based biomarkers are not documented as standard practice within either HSA or private providers. In cases requiring biomarker clarification, clinicians rely on overseas consultations and external laboratory testing.
Treatment & Care
Treatment & care
Show moreSpecialist and long-term dementia care in the Cayman Islands relies on public–private and NGO-government collaboration. HSA provides core neurological, psychiatric, geriatric, imaging, and inpatient services, while Health City Cayman Islands offers dedicated Memory Clinic care. Insurance usually covers treatment and follow-up, but basic SHIC plans provide narrower benefits, potentially leaving families to self-fund specialist care, cognitive testing, rehabilitation, or faster private access. CINICO and comprehensive plans offer broader coverage, although overseas treatment may require approval and incur travel costs. ADACI is central to caregiver support, providing training, home-safety assessments, psychosocial assistance, navigation, and awareness activities. DCFS Elderly Services coordinates home support and residential placements, supplemented by private and NGO facilities. Palliative care is available through medical, community, and private providers, but formal dementia-specific end-of-life protocols have not been established.
Specialized facilities and services
The Cayman Islands has a mixed public–private dementia-care system, with HSA providing neurology, psychiatry, geriatric, radiology, and inpatient services and Health City Cayman Islands offering a dedicated Memory Clinic. ADACI complements clinical care through caregiver education, training, navigation, and dementia-friendly initiatives. The Department of Children & Family Services provides broader social support, including needs assessments, home and community services, elder protection, and residential care for vulnerable older adults. Palliative and end-of-life support is available through hospitals, community nursing, and private providers. However, dementia-specific palliative protocols are not formally published, with care generally following broader palliative standards.
Dementia diagnosis and treatment in the Cayman Islands are primarily delivered through a mixed public–private clinical ecosystem. The HSA provides core services, neurology, psychiatry, geriatric assessment, radiology, and inpatient care, forming the backbone of clinical dementia management. Several private hospitals and specialty clinics supplement this capacity, most notably Health City Cayman Islands, which publicly advertises a dedicated Memory Clinic offering targeted diagnostic assessments, cognitive testing, and follow-up management. This dual system allows most patients to choose between public pathways (typically involving insurance-plan approval) and private providers that may offer shorter waiting times or more specialized evaluation.
Community facing dementia support is led by the ADACI, which anchors non-clinical services such as navigation, education, carer training, and community awareness campaigns. ADACI also collaborates with government and health providers to support early recognition and dementia-friendly initiatives. On the social care side, the Department of Children & Family Services (DCFS) plays a critical statutory role: it conducts needs assessments, responds to elder abuse and neglect reports, coordinates home- and community-based supports, and operates residential care facilities for older persons with significant social or financial vulnerabilities, including the Golden Age Home, Maple House, and Habakkuk House.
Palliative and end-of-life care is available through hospital oncology services, community nursing pathways, and private sector providers. While dementia-specific palliative protocols are not formally published, practice typically aligns with general palliative care standards, focusing on symptom control, caregiver support, and coordinated planning between medical and social care teams.
Approved medication
| Generic Name | Trade Name | Used for |
|---|---|---|
| Donepezil | Aricept, Aricept ODT, Adlarity, Eranz, Memac, Alzepil, Davia, Donecept, Donep, Donepex, Donesyn, Dopezil, Yasnal, Memorit, Pezale, Redumas, Zolpezil, Namzaric* | Donepezil is indicated for the symptomatic treatment of mild to moderately severe Alzheimer’s dementia. |
| Rivastigmine | Exelon, Exelon Patch, Prometax, Rivastach, Nimvastid | Symptomatic treatment of mild to moderately severe Alzheimer’s dementia. Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson’s disease. |
| Galantamine | Razadyne, Razadyne ER, Reminyl, Reminyl XL, Nivalin, Lycoremine, Galsya | Galantamine is indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type. |
| Memantine | Namenda, Namenda XR, Ebixa, Memary, Axura, Akatinol, Maruxa, Nemdatine, Namzaric* | Treatment of adult patients with moderate to severe Alzheimer’s disease. |
*Namzaric = combination of Donepezil and Memantine
Treatment cost
Follow-up dementia care in the Cayman Islands is generally insurance-funded, but coverage varies between plans. Basic SHIC policies may provide limited benefits for specialist consultations, neuropsychological testing, rehabilitation, and imaging, with strict conditions for overseas treatment. Comprehensive private plans and CINICO offer broader coverage, although prior authorisation may be required. Families sometimes self-pay for faster private assessment or treatment, while overseas referrals can create additional travel and accommodation expenses even when medical costs are covered.
Costs associated with follow-up visits, imaging, and symptomatic medications are usually claimable under the patient’s health insurance plan, but the degree of coverage varies significantly. SHIC basic plans often carry more limited outpatient benefits: gaps may arise for specialist consultations, neuropsychological testing, rehabilitative therapies, and certain imaging modalities. These plans also restrict overseas coverage to services judged medically essential and unavailable locally.
By contrast, comprehensive private insurance plans and the various CINICO categories (civil servants, pensioners, veterans/seafarers, indigent persons) tend to cover a broader basket of services, though prior approval is required for any overseas referral or high cost investigation. Families frequently choose self-pay for private specialist consultations, imaging, or faster access to diagnostic testing when insurance restrictions or waiting times pose barriers. As in other Caribbean territories, travel and lodging costs for overseas care often fall partly or fully on the patient.
- https://cinico.ky/wp-content/uploads/2024/09/CINICO_Docs_Summary-Plan_final-092024.pdf
- https://caymanresident.com/health/health-insurance/health-insurance-plans
- https://www.caymancompass.com/2024/10/17/cinico-keeping-cayman-covered/
- https://caymanresident.com/health/health-insurance/health-insurance-plans
Caregiver support
Dementia caregiver support in the Cayman Islands is built around collaboration between ADACI, government social services, and residential providers. ADACI offers caregiver training, home-safety assessments, navigation, psychosocial support, and awareness initiatives, supported through government funding agreements. DCFS Elderly Services assesses needs, coordinates home support, and facilitates residential care, while organisations such as The Pines Retirement Home provide additional long-term capacity. This partnership delivers broad support, although provision remains fragmented and reliant on NGO involvement.
Caregiver support represents a major pillar of Cayman’s dementia response. ADACI delivers caregiver training programs, home safety assessments, navigation assistance, psychosocial support, and public awareness campaigns. Its activities include Dementia Friends training, memory cafés, and general community education aimed at reducing stigma and promoting early help-seeking. The Cayman Islands Government has formally recognized this role: purchase agreements for 2024–2025 allocate public funding to ADACI in exchange for specific outreach, education, and support outputs.
Within statutory social services, DCFS Elderly Services teams coordinate care planning, assess eligibility for home-support packages, and facilitate access to residential care options for individuals who cannot be safely managed in the community. Beyond the public sector, other NGOs, such as The Pines Retirement Home, add long-term care capacity, especially for people requiring continuous supervision or those with advanced dementia. Together, these clinical and social care actors form a patchwork system that relies heavily on NGO-government partnership to deliver holistic dementia support.
Policy
Policy
Show moreThe Cayman Islands lacks a dedicated dementia strategy or legislation, relying on broader ageing, mental health, and healthcare frameworks. The Older Persons Policy 2016–2035 establishes priorities for healthy ageing, safeguarding, inclusion, and long-term care, with the Older Persons Law (2017) creating a statutory advisory Council. The Mental Health Act (2021 Revision) and Health Care Decisions Law (2019) provide safeguards relevant to capacity, compulsory care, advance directives, and healthcare proxies, but do not create comprehensive dementia-specific pathways or standards. Regulatory gaps remain around guardianship, driving, long-term-care quality, governance, and equitable access. Policy implementation currently centres on dementia-friendly workforce training, Dementia Friends campaigns, age-friendly healthcare pilots, and community-based support, with ADACI publicly funded in 2024–2025. This partnership model complements a strongly family-centred care culture, but stigma, misconceptions about ageing, privacy concerns, and unequal resources can delay diagnosis and increase caregiver burden.
National dementia plan
The Cayman Islands lacks a dementia-specific national strategy, relying instead on broader ageing, mental health, and healthcare legislation. The Older Persons Policy 2016–2035 provides a framework for healthy ageing, safeguarding, inclusion, and long-term care, with the Older Persons Law (2017) establishing a statutory advisory Council to identify service and legislative gaps. Dementia-related capacity and crisis issues may fall under the Mental Health Act (2021 Revision), which includes safeguards for compulsory care. The Health Care Decisions Law (2019) complements this framework by recognising advance directives and healthcare proxies. However, these instruments do not establish dedicated dementia pathways, care standards, or funding.
The Cayman Islands do not have a dementia-specific national plan, and dementia policy sits within a broader framework for ageing and mental health. The cornerstone document is the Older Persons Policy 2016–2035, which outlines commitments to healthy ageing, safeguarding, inclusion, and improved access to long-term care services. Its implementation is supported by the Older Persons Law/Act (2017), which formally established the Council of Older Persons, a statutory advisory body charged with reviewing legislation, evaluating gaps in services, advising the Cabinet, and promoting programs for people aged 65 and over. These instruments collectively provide the structural basis for elder policy but stop short of defining dementia pathways, standards, or dedicated funding streams.
Mental health governance intersects with dementia care through the Mental Health Act (2021 Revision), which sets out criteria for compulsory care, safeguards, appeals processes, and the organization of mental health services. Although primarily oriented toward psychiatric conditions, it functions as the main legal vehicle for crisis intervention in dementia when a person lacks decision-making capacity or poses a risk. Complementing this, the Health Care Decisions Law (2019) provides a framework for advance directives, allowing individuals to specify treatment preferences or appoint proxies, an important component of dementia-aligned rights-based care, even if not written specifically for dementia.
- https://parliament.ky/wp-content/uploads/2022/05/12436428.pdf
- https://legislation.gov.ky/cms/images/LEGISLATION/PRINCIPAL/2017/2017-0014/2017-0014_Act%2014%20of%202017_g.pdf
- https://gov.ky/web/opc
- https://legislation.gov.ky/cms/images/LEGISLATION/PRINCIPAL/2013/2013-0010/2013-0010_2021%20Revision.pdf
- https://www.caymanlawschool.ky/n0c-storage/legislation2/health_care_decisions_law_2019.pdf
- https://moh.gov.bn/wp-content/uploads/2024/10/FINAL-MOH-Strategic-Book-2019-compressed-5MB-1.pdf
Upcoming plans
Recent Cayman Islands initiatives focus on implementing the Older Persons Policy and strengthening dementia-aware services rather than introducing a dedicated strategy. Measures include dementia-friendly workforce training, expanded Dementia Friends activities, and age-friendly healthcare pilots. Government funding for ADACI during 2024–2025 further supports community education, caregiver training, navigation, and awareness through NGO-government collaboration.
While no new dementia strategy is announced, government policy statements and budget documents highlight efforts to implement the Older Persons Policy and expand age friendly and dementia-aware services. Recent initiatives include dementia-friendly training for frontline health workers, expansion of Dementia Friends campaigns in schools, churches and workplaces, and pilot projects exploring age-friendly improvements in hospitals and clinics.
Purchase agreements for 2024–2025 confirm ongoing public funding for ADACI, enabling sustained delivery of caregiver training, community education, navigation assistance, and awareness activities.3 This signals a partnership-based policy model, whereby dementia service expansion relies heavily on government, NGO collaboration rather than new statutory pathways or large-scale system redesign. Broader strategy documents, such as those emerging from My eGov and ministerial updates, continue to emphasize strengthening long-term care capacity, improving elder protections, and expanding community-based supports.
- https://parliament.ky/wp-content/uploads/2022/05/12436428.pdf
- https://www.caymancompass.com/2023/09/30/cayman-aims-to-become-dementia-friendly-destination
- https://legislation.gov.ky/cms/images/LEGISLATION/PRINCIPAL/2017/2017-0014/2017-0014_Act%2014%20of%202017_g.pdf
- https://my.egov.ky/documents/d/dfa/msdi-community-resource-guide-january-2025-pdf
Policy gaps
Legal barriers
Cayman’s dementia-related legal framework remains largely indirect, with no dedicated legislation defining rights, clinical responsibilities, or standards of care. General laws, including the Mental Health Act (2021 Revision) and Health Care Decisions Law (2019), provide relevant safeguards but do not establish dementia-specific pathways for capacity assessment, guardianship, supported decision-making, driving, or behavioural risks. Residential and community services also lack specialised regulatory requirements for staffing, training, and dementia-appropriate environments. Responsibility is dispersed among government bodies, healthcare providers, insurers, NGOs, and private facilities, contributing to inconsistent access and coordination. Dementia care therefore remains dependent on discretionary practice and personal resources rather than comprehensive statutory entitlements.
Cayman’s current legal framework provides only indirect coverage of dementia-related issues, resulting in structural gaps across capacity, safeguarding, long-term care, and governance. There is no dementia-specific statute that defines clinical responsibilities, care standards, or rights-based safeguards for people living with cognitive impairment. Instead, dementia is managed under broader legislation such as the Mental Health Act (2021 Revision) and general consent laws, which are not tailored to the progressive, fluctuating, and multidisciplinary nature of dementia.
Key gaps include:
• Capacity and guardianship: There is no unified legal pathway for routine capacity evaluations, durable guardianship, or supported decision-making specific to dementia. Families often rely on ad hoc legal advice or the general provisions of the Health Care Decisions Law (2019), which covers advance directives but does not address day-to-day capacity questions or behavioural risk management.
• Driving and safety regulations: Unlike some jurisdictions with explicit dementia protocols for driving fitness, reporting duties, and periodic reassessment, Cayman relies on general medical judgment, leaving variation in practice and uncertainty for clinicians, families and insurers.
• Long-term care standards: Residential and community dementia care is not governed by specialized regulations that define staffing ratios, training requirements, behavioural care approaches, or environmental design principles. Facilities operate under general elder-care or disability frameworks, which may not fully accommodate complex dementia needs.
• Integrated elder-care governance: Policy oversight is fragmented across HSA, DCFS, NGOs, private insurers, and private long-term care providers. Without a central coordinating statute or dementia plan, responsibilities for quality assurance, funding, and case coordination remain dispersed, causing duplication in some areas and gaps in others.
• Insurance and access pathways: The legal structure of insurance (including SHIC minimum benefits) does not guarantee equal access to diagnostic or rehabilitative services, leading to tiered access depending on insurance class. This gap is not formally addressed in existing health or elder policy instruments.
Overall, the absence of a dedicated legal and policy framework leaves dementia care dependent on institutional discretion, personal resources, and negotiated arrangements rather than clearly defined rights and entitlements.
Cultural barriers
Dementia care in the Cayman Islands remains strongly family-centred, with relatives frequently responsible for recognising changes, arranging services, and providing long-term support. Cultural expectations may favour keeping people at home, while stigma and misconceptions about dementia can postpone assessment. Formal support is not universally accepted, with privacy concerns, generational attitudes, and fear of community judgement sometimes discouraging respite or residential care. Differences in financial resources, health literacy, employment flexibility, and insurance coverage further shape access to specialist or overseas services. Although awareness programmes are improving understanding, limited discussion of dementia progression, advance directives, and end-of-life wishes can impede shared decision-making and increase caregiver strain.
Cultural expectations in the Cayman Islands shape dementia care as strongly as formal policy, often reinforcing a system in which families carry most of the responsibility for recognizing symptoms, coordinating services and sustaining daily care. Family caregiving is deeply valued and widely assumed to be the default response, yet this model places significant emotional and financial pressure on households. Many families attempt to manage dementia at home for as long as possible, sometimes interpreting early cognitive changes as a normal part of ageing or as a private family issue rather than a condition requiring medical attention. As a result, help-seeking is frequently delayed, leading to later-stage diagnosis and more complex care needs by the time specialist input is sought.
Stigma surrounding cognitive impairment still persists, particularly in smaller districts where community familiarity can amplify concerns about embarrassment or social judgment. Although awareness initiatives such as Dementia Friends have begun to shift perceptions, the lingering belief that dementia is an inevitable and untreatable part of old age continues to reduce early engagement with services. Informal care networks, while culturally valued, create uneven access to care: families with greater financial means, higher health literacy or more flexible employment arrangements are better positioned to navigate specialist referrals, insurance requirements and the logistics of overseas diagnostics, whereas others may face overwhelming barriers.
Acceptance of formal support services, such as respite care, home-help programs or long-term residential care, remains variable. Some households avoid external assistance due to cultural preference, generational attitudes, privacy concerns or fears of judgment from the community. This reluctance can lead to caregiver exhaustion and missed opportunities for earlier intervention. Communication challenges further complicate the picture: differences in understanding between clinicians and families, unfamiliarity with dementia terminology, and limited discussion about the progressive trajectory of the disease often hinder shared decision-making. Conversations about advance directives, long-term planning and end-of-life wishes remain uncommon, contributing to uncertainty later in the disease course.
Research
Research
Show moreThe Cayman Islands’ dementia innovation is primarily service- and community-based, with no identified local Alzheimer’s drug or device trials and limited infrastructure for large-scale clinical research. Health City and HSA have implemented dementia-friendly training, while Dementia Friends extends awareness across schools, workplaces, and tourism. Access to advanced research, amyloid imaging, anti-amyloid therapies, and observational studies therefore generally depends on overseas referral, particularly to the US.
Selected academic institutions
Clinical trials and registries
A search of ClinicalTrials.gov and EU/UK trial registries shows no active or recently completed Alzheimer’s drug or device trials conducted in the Cayman Islands. Given the jurisdiction’s population size, regulatory structure, and limited academic infrastructure, Cayman is not used as a site for Phase II–III therapeutic trials. Participation in clinical research generally occurs through overseas referral pathways, particularly to the US, where families with adequate insurance or financial means may pursue access to anti-amyloid therapies, specialist imaging (e.g., amyloid PET), or enrollment in observational cohorts.
Selected innovative methods
The Cayman Islands’ dementia innovation focuses on practical, community-based programmes. Health City and HSA are strengthening dementia-friendly healthcare through staff training, improved communication, and environmental adaptations. Dementia Friends has expanded into schools, workplaces, and tourism settings, supporting stigma reduction and earlier help-seeking. Together, these initiatives build dementia awareness across healthcare, community, and private-sector environments.
Innovation in Cayman’s dementia response is programmatic rather than laboratory-based. Health City Cayman Islands has promoted dementia-friendly training within its facilities, focusing on environmental adjustments, staff communication skills, and practices that reduce confusion or distress for patients with cognitive impairment. HSA units have adopted elements of similar training, particularly within emergency and outpatient settings.
A significant strand of innovation comes from community-level initiatives, especially the expansion of Dementia Friends, adapted for schools, corporate settings, and tourism operators. The aim is to reduce stigma, encourage earlier engagement with healthcare services, and improve front-line responses in public facing environments (hotels, retail, transport, hospitality). These programmatic innovations serve as capacity-builders in a system without large-scale research infrastructure, helping create a dementia-aware ecosystem across health, social care, and the private sector.
Support
Support
Show moreADACI is the main driver of dementia awareness and information in the Cayman Islands, supporting World Alzheimer’s Month, educational activities, media outreach, and Dementia Friends across community and workplace settings. It also provides practical caregiver and navigation support. As no specialised dementia media outlet exists, public information is channelled through ADACI, government agencies, the Council of Older Persons, HSA, and Health City, particularly during annual awareness campaigns.
Selected national associations, patient family associations, NGOs:
Selected initiatives
Cayman’s dementia awareness landscape is driven by ADACI, particularly through World Alzheimer’s Month activities, public education, and memory-awareness events. Dementia Friends has broadened participation across schools, workplaces, churches, businesses, and hospitality. ADACI additionally provides caregiver skills training and navigation support, while Health City’s dementia-friendly initiative strengthens frontline staff readiness and care environments.
Cayman participates annually in World Alzheimer’s Month, led largely by ADACI in collaboration with government partners. Activities include educational workshops, public lectures, media campaigns, and memory-awareness events aimed at reducing stigma and promoting earlier recognition of symptoms.
Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/bcdafabe/public_html/wp-content/themes/bricks-child/functions.php on line 753
The Dementia Friends program has achieved significant local penetration, extending into public-sector agencies, banks, churches, hospitality providers, and schools. ADACI also offers home-safety assessments, caregiver skills training, and community navigation support to families adjusting to new diagnoses.
Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/bcdafabe/public_html/wp-content/themes/bricks-child/functions.php on line 753
On the provider side, Health City’s dementia-friendly facility initiative represents a structured approach to environmental adaptation and staff training aligning with international best practices for front-line dementia care. Collectively, these initiatives compensate for the absence of a national dementia strategy by building a grassroots network of awareness, practical skills, and front-line readiness.
Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/bcdafabe/public_html/wp-content/themes/bricks-child/functions.php on line 753
Dedicated media outlets
Cayman does not have media outlets devoted exclusively to dementia. Information circulates through ADACI’s website and social media, government channels such as DCFS, the Council of Older Persons, and communications from health providers (HSA and Health City). Coverage tends to intensify during World Alzheimer’s Month, with periodic features highlighting caregiver stories, training efforts, or policy initiatives. In a small jurisdiction with limited specialized media, NGOs effectively function as the primary public information hubs for dementia-related content.
